First person gets new experimental vaccine for Ebola
Summary
A 37-year-old man in the UK is the first person to receive a new experimental vaccine against the Ebola virus. The vaccine was made in Oxford using the same technology as the Oxford AstraZeneca Covid vaccine, and it is being tested for safety and immune response.Key Facts
- The first volunteer is a 37-year-old UK man named Ed Hunt.
- The vaccine targets the Bundibugyo strain of Ebola, which is causing an outbreak in the Democratic Republic of Congo.
- The vaccine was developed in just eight weeks by scientists in Oxford.
- The vaccine uses the same technology as the Oxford AstraZeneca Covid vaccine.
- The trial is a phase one study to check safety and whether it triggers immune protection.
- The Oxford team plans further trials in Uganda and DR Congo to test if the vaccine works well.
- A vaccine exists for a different Ebola strain (Zaire), but it does not protect against Bundibugyo.
- The Serum Institute in India has produced 600,000 doses ready for use if the vaccine passes tests.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
